During the past decade, Amicis Research Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 2 clinical trials were completed, i.e. on average, 8% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 2 clinical trials were completed. i.e. 9.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Amicis Research Center" #1 sponsor was "Goldfinch Bio, Inc." with 2 trials, followed by "Horizon Therapeutics Ireland DAC" with 2 trials sponsored, "Aldeyra Therapeutics, Inc." with 1 trials sponsored, "Allena Pharmaceuticals" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Amicis Research Center" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Amicis Research Center" are "Glomerulonephritis" (2 trials), "Kidney Diseases" (2 trials), "Nephritis" (2 trials), "Nephrosis" (2 trials) and "Uncontrolled Gout" (2 trials). Many other conditions were trialed in "Amicis Research Center" in a lesser frequency.

Most popular intervention types in "Amicis Research Center" are "Drug" (19 trials), "Biological" (3 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "GFB-887" (2 trials), "ADX-629" (1 trials), "AND017" (1 trials) and "AlloSure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Amicis Research Center" are 25 trials for "All" genders.

Currently, there are 17 active trials in "Amicis Research Center". 1 are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Amicis Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Amicis Research Center, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".